Company Filing History:
Years Active: 2017
Title: Ana Merino-Trigo: Innovator in Cancer Treatment
Introduction
Ana Merino-Trigo is a prominent inventor based in Paris, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents.
Latest Patents
Ana holds a patent for "Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereof." This patent involves antibodies that specifically bind to human lysosomal-associated membrane protein 1 (LAMP1) proteins. The invention includes immunoconjugates that are linked to growth inhibitory agents. Furthermore, it provides pharmaceutical compositions that utilize these antibodies or immunoconjugates for cancer treatment. The application also discusses the detection of LAMP1 gene amplification in cancer cells, which can help determine if patients are likely to respond to anti-LAMP1 therapy.
Career Highlights
Ana is currently associated with Sanofi, a leading global healthcare company. Her work focuses on developing innovative solutions for cancer treatment, showcasing her commitment to advancing medical science.
Collaborations
Ana has collaborated with notable colleagues, including Yves Baudat and Francis Blanche. These partnerships have contributed to her success in the field of cancer research.
Conclusion
Ana Merino-Trigo is a trailblazer in the development of cancer therapies, with her patent on Anti-LAMP1 antibodies representing a significant advancement in the fight against cancer. Her work continues to inspire and pave the way for future innovations in medical treatment.